Spondylitis News and Research

RSS
Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

Updated recommendations for treatment of patients with axial spondyloarthritis released

Updated recommendations for treatment of patients with axial spondyloarthritis released

IMAS survey reveals 74% of people living with axial spondyloarthritis struggle to find a job

IMAS survey reveals 74% of people living with axial spondyloarthritis struggle to find a job

FDA approves treatment for adults with non-radiographic axial spondyloarthritis

FDA approves treatment for adults with non-radiographic axial spondyloarthritis

ACR and NPF release joint treatment guideline for psoriatic arthritis

ACR and NPF release joint treatment guideline for psoriatic arthritis

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

MSU researchers move one step closer to solving arthritic disease in teenagers

MSU researchers move one step closer to solving arthritic disease in teenagers

Researchers discover new protein that controls level of inflammation-inducing molecule

Researchers discover new protein that controls level of inflammation-inducing molecule

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

Combination of NSAIDs and TNF inhibitors linked to reduced radiographic progression in AS patients

Combination of NSAIDs and TNF inhibitors linked to reduced radiographic progression in AS patients

Price check on drug ads: Would revealing costs help patients control spending?

Price check on drug ads: Would revealing costs help patients control spending?

New study launched to examine effects of rheumatologic agent on bone health

New study launched to examine effects of rheumatologic agent on bone health

Online consultation via mobile app reduces costs and delays for rheumatic disease patients

Online consultation via mobile app reduces costs and delays for rheumatic disease patients

New guidelines for anti-rheumatic drug management in patients having joint replacement surgery

New guidelines for anti-rheumatic drug management in patients having joint replacement surgery

Research findings provide insight into mechanisms underlying differences in efficacy of anti-TNF drugs

Research findings provide insight into mechanisms underlying differences in efficacy of anti-TNF drugs

CreakyJoints publishes new guidelines for rheumatoid arthritis patients and caregivers

CreakyJoints publishes new guidelines for rheumatoid arthritis patients and caregivers

CreakyJoints announces first patient-friendly guidelines for rheumatoid arthritis

CreakyJoints announces first patient-friendly guidelines for rheumatoid arthritis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis